Thinking beyond the common Candida species: Need for species-level identification of Candida due to the emergence of multidrug-resistant Candida auris

Journal of Clinical Microbiology

Volumn 55, Issue 12, 2017, Pages 3324-3327

  Lockhart, Shawn R ^a   Jackson, Brendan R ^a   Vallabhaneni, Snigdha ^a   Ostrosky Zeichner, Luis ^b   Pappas, Peter G ^c   Chiller, Tom ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Candida; Candida auris; Identification

Indexed keywords

ANTIFUNGAL RESISTANCE; CANDIDA; CANDIDA AURIS; FUNGUS IDENTIFICATION; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPECIES IDENTIFICATION; CANDIDIASIS; CLASSIFICATION; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PROCEDURES;

ANTIFUNGAL AGENT;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DRUG RESISTANCE, MULTIPLE, FUNGAL; HUMANS; MICROBIOLOGICAL TECHNIQUES;

EID: 85036637338     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01355-17     Document Type: Review

References (18)

1. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, Ray SM, Thompson DL, Wilson LE, Fridkin SK. 2014. Multistate point-prevalence survey of health care-Associated infections. N Engl J Med 370: 1198-1208. https://doi.org/10.1056/NEJMoa1306801.
2. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39: 309-317. https://doi.org/10.1086/421946.
3. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K. 2009. International study of the prevalence and outcomes of infection in intensive care units. JAMA 302: 2323-2329. https://doi.org/10.1001/jama.2009.1754.
4. Lockhart SR, Iqbal N, Cleveland AA, Farley MM, Harrison LH, Bolden CB, Baughman W, Stein B, Hollick R, Park BJ, Chiller T. 2012. Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol 50: 3435-3442. https://doi.org/10.1128/JCM.01283-12.
5. Castanheira M, Messer SA, Rhomberg PR, Pfaller MA. 2016. Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013). Diagn Microbiol Infect Dis 85: 200-204. https://doi.org/10.1016/j.diagmicrobio.2016.02.009.
6. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD. 2016. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 62: e1-e50. https://doi.org/10.1093/cid/civ1194.
7. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, Rodloff A, Fu W, Ling TA. 2010. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol 48: 1366-1377. https://doi.org/10.1128/JCM.02117-09.
8. Kao AS, Brandt ME, Pruitt WR, Conn LA, Perkins BA, Stephens DS, Baughman WS, Reingold AL, Rothrock GA, Pfaller MA, Pinner RW, Hajjeh RA. 1999. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 29: 1164-1170. https://doi.org/10.1086/313450.
9. Chowdhary A, Voss A, Meis JF. 2016. Multidrug-resistant Candida auris: 'new kid on the block' in hospital-Associated infections? J Hosp Infect 94: 209-212. https://doi.org/10.1016/j.jhin.2016.08.004.
10. Chowdhary A, Sharma C, Meis JF. 2017. Candida auris: a rapidly emerging cause of hospital-Acquired multidrug-resistant fungal infections globally. PLoS Pathog 13: e1006290. https://doi.org/10.1371/journal.ppat.1006290.
11. Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, Ryan L, Shackleton J, Trimlett R, Meis JF, Armstrong-James D, Fisher MC. 2016. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control 5: 35. https://doi.org/10.1186/s13756-016-0132-5.
12. Calvo B, Melo AS, Perozo-Mena A, Hernandez M, Francisco EC, Hagen F, Meis JF, Colombo AL. 2016. First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia. J Infect 73: 369-374. https://doi.org/10.1016/j.jinf.2016.07.008.
13. Tsay S, Welsh RM, Adams EH, Chow NA, Gade L, Berkow EL, Poirot E, Lutterloh E, Quinn M, Chaturvedi S, Kerins J, Black SR, Kemble SK, Barrett PM, Barton K, Shannon DJ, Bradley K, Lockhart SR, Litvintseva AP, Moulton-Meissner H, Shugart A, Kallen A, Vallabhaneni S, Chiller TM, Jackson BR. 2017. Notes from the field: ongoing transmission of Candida auris in health care facilities-United States, June 2016-May 2017. MMWR Morb Mortal Wkly Rep 66: 514-515. https://doi.org/10.15585/mmwr.mm6619a7.
14. Arendrup MC, Prakash A, Meletiadis J, Sharma C, Chowdhary A. 2017. Comparison of EUCAST and CLSI reference microdilution MICs of eight antifungal compounds for Candida auris and associated tentative epidemiological cutoff values. Antimicrob Agents Chemother 61: e00485-17. https://doi.org/10.1128/AAC.00485-17.
15. Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, Colombo AL, Calvo B, Cuomo CA, Desjardins CA, Berkow EL, Castanheira M, Magobo RE, Jabeen K, Asghar RJ, Meis JF, Jackson B, Chiller T, Litvintseva AP. 2017. Simultaneous emergence of multidrugresistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 64: 134-140. https://doi.org/10.1093/cid/ciw691.
16. Magobo RE, Corcoran C, Seetharam S, Govender NP. 2014. Candida aurisassociated candidemia, South Africa. Emerg Infect Dis 20: 1250-1251. https://doi.org/10.3201/eid2007.131765.
17. Chowdhary A, Sharma C, Duggal S, Agarwal K, Prakash A, Singh PK, Jain S, Kathuria S, Randhawa HS, Hagen F, Meis JF. 2013. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis 19: 1670-1673. https://doi.org/10.3201/eid1910.130393.
18. Mizusawa M, Miller H, Green R, Lee R, Durante M, Perkins R, Hewitt C, Simner PJ, Carroll KC, Hayden RT, Zhang SX. 2017. Can multidrugresistant Candida auris be reliably identified in clinical microbiology laboratories? J Clin Microbiol 55: 638-640. https://doi.org/10.1128/JCM.02202-16.